ReviewFrontiers in immunology2025
Factor B as a therapeutic target for the treatment of complement-mediated diseases.
David Kavanagh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papertrialcites it
ReviewFrontiers in immunology2025
David Kavanagh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.